Sołowow invests in firm fighting with cancer
13:13
NanoVelos welcomes Mr Michał Sołowow as a key shareholder (via IPOPEMA 112 FIZ AN). The current investment round is meant to launch the clinical study of the NanoVelos' nanoparticles carying doxorubicin.
